Healthcare
AddLife AB (publ)(ADDLF)
Live Price
Offline$15.75
+0.00% today
1Y Change
-62.50%
Window
Jun 25, 2025 โ Jun 19, 2026
- Market Cap
- $16.74B
- Revenue Growth
- +1.5%
- EPS Growth
- +121.7%
- Dividend Yield
- 0.5%
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
AddLife AB (publ) (ADDLF) is a Healthcare stock with a market cap of $16.74B and listed on OTC. The stock last traded around $15.75 and down 62.5% across the available one-year price window (Jun 25, 2025 โ Jun 19, 2026). Baseline metrics include revenue growth of +1.5%, EPS growth of +121.7%, a dividend yield of 0.5%. What stands out right now is revenue +1.5%, EPS +121.7%, free cash flow +74.4% with operating margin 7.5% and ROIC 5.2%. The dividend is present but secondary, with a yield around 0.5%. Valuation already assumes a fairly strong business story at P/E 30.6 and price/sales 1.6. Stock Foundry combines ADDLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+1.5% vs +7.6% peer median
Operating Margin
Below sector median
+7.5% vs +19.4% peer median
P/E
Below sector median
30.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 28, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +1.5% and EPS at +121.7%, with operating margin around 7.5%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.5%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 28, 2026 | โ | +0.0% | +0.0% | -62.5% |
2026 Feb 4, 2026 | +19.8% | +0.0% | +0.0% | +0.0% |
2025 Oct 23, 2025 | +5.4% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
ADDLF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ADDLF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ADDLF Max Drawdown
-62.50%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ADDLF and SPY.
Company Overview
AddLife AB (publ)
Other OTC
AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
- Leadership
- Fredrik Dalborg
- IPO Date
- Nov 27, 2018
- Employees
- 2.3k
- Street Address
- Brunkebergstorg 5
- Mailing
- Stockholm, 103 62
- Region
- Stockholm, SE
- Reporting Currency
- USD
- Investor Line
- 46 8 42 00 38 30
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 30.6
- EV/EBITDA
- 14.9
- Price/Sales
- 1.6
- Price/Book
- 3.1
Growth
- Revenue
- +1.5%
- EPS
- +121.7%
- Free Cash Flow
- +74.4%
Profitability
- Gross Margin
- 38.3%
- Operating Margin
- 7.5%
- Net Margin
- 5.5%
- ROE
- 10.5%
- ROIC
- 5.2%
Balance Sheet
- Debt/Equity
- 0.85
- Current Ratio
- 1.08
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.